In vivo Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 HIV-1 Kick

Overview of attention for article published in Frontiers in immunology, March 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 9 X users

Readers on

mendeley: 43 Mendeley

Summary X

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 49,507 followers.

New #UPCommons #Eprints "In vivo effects of romidepsin on T-cell activation, apoptosis and function in the BCN02 HIV-1 kick&kill clinical trial" https://t.co/rn4d66Kx89

27 Apr 2021

Reply Repost Favourite

New Research: In vivo Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 HIV-1 Kick&Kill Clinical Trial: Romidepsin (RMD) is a well-characterized histone deacetylase inhibitor approved for the treatment of… https://t.co/jOO

26 Apr 2020

Reply Repost Favourite

RT @TAGHIVscience: In vivo Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 #HIV-1 Kick & Kill Clinical Tria…

09 Apr 2020

Reply Repost Favourite

New article: In vivo Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 HIV-1 Kick&Kill Clinical Trial. https://t.co/DS3mGUJBjp #TCL #lymsm #hematology

09 Apr 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.